Peripheral Nerve Society
Membership Organizations · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1935 County Road B2 W Ste 165, Roseville...Phone Number
(952) 545-6284Website
www.pnsociety.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Peripheral Nerve Society
The Peripheral Nerve Society is an international non-profit organization dedicated to improving the lives of individuals with peripheral neuropathies. It brings together scientists, physicians, and healthcare providers to support research, education, and treatment standards for peripheral nervous system diseases. The society offers various resources, including training grants, educational courses, and a job board, aimed at both professionals and patients. Through initiatives like the Peripheral Nerve Podcast, it seeks to enhance awareness and understanding of peripheral nerve disorders.Explore more
Peripheral Nerve Society Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Peripheral Nerve Society your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Peripheral Nerve Society launches new products
Click to see if Peripheral Nerve Society had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Peripheral Nerve Society recently announced quarterly report
Check if Peripheral Nerve Society has recently received funding, and reach out quickly before it becomes old news!
Check out if Peripheral Nerve Society is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Peripheral Nerve Society
Peripheral Nerve Society, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Peripheral Nerve Society has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Peripheral Nerve Society
Compare insights from companies similar to Peripheral Nerve Society, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
<$5M
1975
TD
Terri DeFlorianExecutive Director, Academy of Orthopaedic Physical Therapy, APTA
Company Profile Activity
Activity Insights
Peripheral Nerve Society is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Peripheral Nerve Society is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Peripheral Nerve Society.
Peripheral Nerve Society Tech Stack
A closer look at the technologies used by Peripheral Nerve Society
Peripheral Nerve Society News & Media
CMTA Presents New Genetic Landscape Analysis at The 2025 Annual Meeting of the Peripheral Nerve Society
CMTA presents findings at PNS 2025, revealing 135 CMT genes and 169 subtypes, highlighting the need for continued research to improve diagnosis and care. GLENOLDEN, PA, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- The Charcot-Marie-Tooth …Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Slowing of progression of disease observed via MRI at 24 monthsIntellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting
CAMBRIDGE, Mass., May 18, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced positive two-year follow-up data from the ongoing Phase 1 trial of investigational nexiguran ziclumeran (nex-z) for the treatment of hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN). Results were shared in an oral presentation on Sunday, May 18 at the 2025 Peripheral NHansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS
LUND, Sweden, May 14, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome (GBS) at the Peripheral Nerve Society (PNS)...
Read more news
Top Membership Organizations Companies
Frequently Asked Questions Regarding Peripheral Nerve Society
Sign Up For FreeTo access detailed company insights
The Peripheral Nerve Society is an international non-profit organization dedicated to improving the lives of individuals with peripheral neuropathies. It brings together scientists, physicians, and healthcare providers to support research, education, and treatment standards for peripheral nervous system diseases. The society offers various resource... Read More
